메뉴 건너뛰기




Volumn 22, Issue 5, 2012, Pages 2052-2062

Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na v1.7 antagonists

Author keywords

Congenital indifference to pain; Na v channels; Na v1.7; Paroxysmal extreme pain disorder; Primary erythromelalgia; Pyrrolopyrimidine; Sodium channel antagonists; Sodium channel blockers; Sodium channel inhibitors; Voltage gated sodium channels

Indexed keywords

METHYL GROUP; POTASSIUM CHANNEL HERG; PYRAZOLOPYRIMIDINE DERIVATIVE; PYRROLOPYRIMIDINE DERIVATIVE; SODIUM CHANNEL NAV1.7;

EID: 84862782527     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.01.015     Document Type: Article
Times cited : (27)

References (18)
  • 10
    • 84862809997 scopus 로고    scopus 로고
    • Compound 1 was commercially obtained
    • Compound 1 was commercially obtained.
  • 14
    • 84862786727 scopus 로고    scopus 로고
    • 3, acetic acid, DCE, yield 62%
    • 3, acetic acid, DCE, yield 62%.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.